GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 89 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $30,079 | -10.2% | 17,488 | +1.9% | 0.00% | – |
Q2 2023 | $33,477 | -46.0% | 17,168 | +14.1% | 0.00% | – |
Q1 2022 | $62,000 | -74.5% | 15,041 | -20.5% | 0.00% | – |
Q4 2021 | $243,000 | +153.1% | 18,912 | +80.5% | 0.00% | – |
Q2 2021 | $96,000 | -4.0% | 10,476 | -5.8% | 0.00% | – |
Q4 2019 | $100,000 | – | 11,121 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 4,450,638 | $41,970,000 | 8.18% |
Copernicus Capital Management, LLC | 37,000 | $349,000 | 5.64% |
EcoR1 Capital, LLC | 3,421,287 | $32,263,000 | 1.43% |
Palo Alto Investors LP | 2,298,382 | $21,674,000 | 1.24% |
AlpInvest Partners B.V. | 226,866 | $2,139,000 | 1.06% |
Stenahm Asset Managment Ltd | 150,000 | $1,415,000 | 1.00% |
FRAZIER MANAGEMENT LLC | 1,030,878 | $9,721,000 | 0.78% |
BVF INC/IL | 1,861,239 | $17,551,000 | 0.66% |
Avidity Partners Management LP | 2,122,064 | $20,011,000 | 0.55% |
Redmile Group, LLC | 2,448,158 | $23,086,000 | 0.32% |